170 related articles for article (PubMed ID: 21782240)
1. Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature.
Mathew RA; Bennett JM; Liu JJ; Komrokji RS; Lancet JE; Naghashpour M; Messina JL; List AF; Moscinski LC; Zhang L
Leuk Res; 2012 Jan; 36(1):72-80. PubMed ID: 21782240
[TBL] [Abstract][Full Text] [Related]
2. Clinical importance of bone marrow monocytic nodules in patients with myelodysplasia: retrospective analysis of 21 cases.
Chen YC; Chou JM; Letendre L; Li CY
Am J Hematol; 2005 Aug; 79(4):329-31. PubMed ID: 16044436
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
[TBL] [Abstract][Full Text] [Related]
4. [Neoplastic skin infiltration in chronic myelomonocytic leukemia].
Wajs J; Zabielski S; Trawiński J
Pol Merkur Lekarski; 2001 Nov; 11(65):427-9. PubMed ID: 11852815
[TBL] [Abstract][Full Text] [Related]
5. Functional alterations of Lin-CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia.
Sun Q; So CC; Yip SF; Wan TS; Ma SK; Chan LC
Leuk Res; 2008 Sep; 32(9):1374-81. PubMed ID: 18372040
[TBL] [Abstract][Full Text] [Related]
6. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
[TBL] [Abstract][Full Text] [Related]
7. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
[TBL] [Abstract][Full Text] [Related]
8. Unusual skin lesions in chronic myelomonocytic leukemia.
McCollum A; Bigelow CL; Elkins SL; Hardy CL; Files JC
South Med J; 2003 Jul; 96(7):681-4. PubMed ID: 12940320
[TBL] [Abstract][Full Text] [Related]
9. Erythrophagocytosis by dysplastic neutrophils in chronic myelomonocytic leukemia and subsequent transformation to acute myeloid leukemia.
Etzell J; Lu CM; Browne LW; Wang E
Am J Hematol; 2005 Aug; 79(4):340-2. PubMed ID: 16044446
[TBL] [Abstract][Full Text] [Related]
10. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.
Shih LY; Lin TL; Wang PN; Wu JH; Dunn P; Kuo MC; Huang CF
Cancer; 2004 Sep; 101(5):989-98. PubMed ID: 15329908
[TBL] [Abstract][Full Text] [Related]
11. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases.
Vitte F; Fabiani B; Bénet C; Dalac S; Balme B; Delattre C; Vergier B; Beylot-Barry M; Vignon-Pennamen D; Ortonne N; Algros MP; Carlotti A; Samaleire D; Frouin E; Levy A; Laroche L; Theate I; Monnien F; Mugneret F; Petrella T
Am J Surg Pathol; 2012 Sep; 36(9):1302-16. PubMed ID: 22895265
[TBL] [Abstract][Full Text] [Related]
12. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Palomo L; Garcia O; Arnan M; Xicoy B; Fuster F; Cabezón M; Coll R; Ademà V; Grau J; Jiménez MJ; Pomares H; Marcé S; Mallo M; Millá F; Alonso E; Sureda A; Gallardo D; Feliu E; Ribera JM; Solé F; Zamora L
Oncotarget; 2016 Aug; 7(35):57021-57035. PubMed ID: 27486981
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of chronic myelomonocytic leukemia.
Catalano L; Improta S; de Laurentiis M; Molica S; Majolino I; Musto P; Fragasso A; De Placido S; Rotoli B
Haematologica; 1996; 81(4):324-9. PubMed ID: 8870376
[TBL] [Abstract][Full Text] [Related]
14. Chronic myelomonocytic leukemia: myeloproliferative variant.
Onida F; Beran M
Curr Hematol Rep; 2004 May; 3(3):218-26. PubMed ID: 15087071
[TBL] [Abstract][Full Text] [Related]
15. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
Estey EH; Keating MJ; Dixon DO; Trujillo JM; McCredie KB; Freireich EJ
Hematol Pathol; 1987; 1(4):203-8. PubMed ID: 3504436
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine.
Adès L; Sekeres MA; Wolfromm A; Teichman ML; Tiu RV; Itzykson R; Maciejewski JP; Dreyfus F; List AF; Fenaux P; Komrokji RS
Leuk Res; 2013 Jun; 37(6):609-13. PubMed ID: 23415110
[TBL] [Abstract][Full Text] [Related]
17. Association of Leukemia Cutis With Survival in Acute Myeloid Leukemia.
Wang CX; Pusic I; Anadkat MJ
JAMA Dermatol; 2019 Jul; 155(7):826-832. PubMed ID: 30969325
[TBL] [Abstract][Full Text] [Related]
18. Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis.
Michel G; Boulad F; Small TN; Black P; Heller G; Castro-Malaspina H; Childs BH; Gillio AP; Papadopoulos EB; Young JW; Kernan NA; O'Reilly RJ
Bone Marrow Transplant; 1997 Jul; 20(2):107-12. PubMed ID: 9244412
[TBL] [Abstract][Full Text] [Related]
19. Chronic myelomonocytic leukemia.
Storniolo AM; Moloney WC; Rosenthal DS; Cox C; Bennett JM
Leukemia; 1990 Nov; 4(11):766-70. PubMed ID: 2232890
[TBL] [Abstract][Full Text] [Related]
20. Blastic Transformation in Mexican Population With Chronic Myelomonocytic Leukemia.
Rivera Duarte A; Armengol Alonso A; Sandoval Cartagena E; Tuna Aguilar E
Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):532-538. PubMed ID: 28842140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
